Systemic Juvenile Idiopathic Arthritis (SJIA) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 31 pages | ID: SE39B681A9BEN
VPAResearch

Abstracts

Systemic Juvenile Idiopathic Arthritis (SJIA) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Systemic Juvenile Idiopathic Arthritis (SJIA) disease clinical trials. The research work analyzes the ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Systemic Juvenile Idiopathic Arthritis (SJIA) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Systemic Juvenile Idiopathic Arthritis (SJIA) clinical trials.

Scope of the Report-

• Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Systemic Juvenile Idiopathic Arthritis (SJIA) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Systemic Juvenile Idiopathic Arthritis (SJIA) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Phase
3.2 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Type
3.3 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials
4.2 Top 10 Countries conducting Systemic Juvenile Idiopathic Arthritis (SJIA) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Sponsor Type
5.2 Systemic Juvenile Idiopathic Arthritis (SJIA) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by year
6.2 Subjects Recruited for Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Phase
6.3 Subjects Recruited for Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Trial Type
6.4 Subjects Recruited for Systemic Juvenile Idiopathic Arthritis (SJIA) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials- Phase
7.2 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials- Phase
7.3 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials- Phase
7.4 Ongoing Systemic Juvenile Idiopathic Arthritis (SJIA) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Country
Figure 2: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Phase of Development, 2018
Figure 3: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Status, 2018
Figure 4: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Type, 2018
Figure 5: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials Split by Region, 2000-2018
Figure 6: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Type of Economy, 2018
Figure 7: Systemic Juvenile Idiopathic Arthritis (SJIA)- Enrolment by Phase, 2018
Figure 8: Systemic Juvenile Idiopathic Arthritis (SJIA)- Enrolment by Trial Type, 2018
Figure 9: Systemic Juvenile Idiopathic Arthritis (SJIA)- Enrolment by Recruitment Status, 2018
Figure 10: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Sponsor Type, 2018
Figure 11: Systemic Juvenile Idiopathic Arthritis (SJIA)- Enrolment by Type of Sponsors
Figure 12: Systemic Juvenile Idiopathic Arthritis (SJIA)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Sponsor Type, 2018
Table 2: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Economy Type, 2018
Table 3: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials by Region, 2018
Table 4: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Systemic Juvenile Idiopathic Arthritis (SJIA)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Systemic Juvenile Idiopathic Arthritis (SJIA)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Systemic Juvenile Idiopathic Arthritis (SJIA)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Systemic Juvenile Idiopathic Arthritis (SJIA)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Systemic Juvenile Idiopathic Arthritis (SJIA)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company